GH,DNLI Stock Price and Quote

Peers: NTRA DGX LH ILMN IQV MEDP A ICLR VEEV RVTY

| Held by: IWM VTI VB VBK IWO VXF SCHA CGGR ARKG FESM

Index	RUT	P/E	-	EPS (ttm)	-3.40	Insider Own	4.24%	Shs Outstand	131.51M	Perf Week	-3.15%
Market Cap	16.66B	Forward P/E	-	EPS next Y	-2.02	Insider Trans	-12.09%	Shs Float	126.98M	Perf Month	36.16%
Enterprise Value	17.26B	PEG	-	EPS next Q	-0.75	Inst Own	103.57%	Short Float	10.18%	Perf Quarter	37.73%
Income	-433.19M	P/S	15.42	EPS this Y	11.72%	Inst Trans	3.79%	Short Ratio	6.02	Perf Half Y	18.54%
Sales	1.08B	P/B	-	EPS next Y	31.21%	ROA	-26.58%	Short Interest	12.93M	Perf YTD	22.98%
Book/sh	-1.38	P/C	15.10	EPS next 5Y	48.05%	ROE	-	52W High	134.28 -6.46%	Perf Year	159.47%
Cash/sh	8.32	P/FCF	-	EPS past 3/5Y	19.67% -4.99%	ROIC	-28.97%	52W Low	40.35 211.26%	Perf 3Y	287.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.75% 27.92%	Gross Margin	64.90%	Volatility	5.04% 5.93%	Perf 5Y	6.73%
Dividend TTM	-	EV/Sales	15.98	EPS Y/Y TTM	-0.63%	Oper. Margin	-41.38%	ATR (14)	6.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.39	Sales Y/Y TTM	39.56%	Profit Margin	-40.10%	RSI (14)	64.05	Recom	1.41
Dividend Gr. 3/5Y	- -	Current Ratio	4.68	EPS Q/Q	-11.14%	SMA20	9.92%	Beta	1.62	Target Price	139.33
Payout	-	Debt/Eq	-	Sales Q/Q	48.26%	SMA50	27.25%	Rel Volume	1.56	Prev Close	133.06
Employees	2506	LT Debt/Eq	-	Earnings	May 07 AMC	SMA200	38.15%	Avg Volume	2.15M	Price	125.61
IPO	Oct 04, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.46% 8.07%	Trades		Volume	3,345,629	Change	-5.60%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-26	Initiated	Goldman	Buy	$165
Jun-02-26	Upgrade	Evercore ISI	In-line → Outperform	$160
Jun-02-26	Resumed	Wolfe Research	Outperform	$150
Feb-20-26	Reiterated	Canaccord Genuity	Buy	$125 → $135
Feb-17-26	Initiated	Robert W. Baird	Outperform	$120
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$105
Dec-02-25	Resumed	Morgan Stanley	Overweight	$130
Sep-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$75
Sep-22-25	Resumed	Wells Fargo	Overweight	$72
Apr-10-25	Initiated	Mizuho	Outperform	$55
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65

Show Previous Ratings

Jun-05-26 09:36AM	Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls (The Fly) -5.60%
Jun-04-26 03:39PM	A new blood test can help detect colon cancer, but it's not as good as the test you hate to take (MarketWatch)
12:13PM	Here's Why This Colon Cancer Testing Biotech Is A Mutual Fund Favorite (Investor's Business Daily)
May-28-26 08:05AM	Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting (Business Wire)
May-27-26 04:06PM	Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test (Investor's Business Daily) +6.39%
07:47AM	Loading…
07:47AM	American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines (Business Wire)
May-21-26 06:00AM	Guardant wins FDA approval for updated liquid biopsy (MedTech Dive)
May-20-26 11:02AM	Guardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out? (Investor's Business Daily) +17.09%
08:05AM	FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint (Business Wire)
May-18-26 04:51PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-07-26 04:46PM	Guardant Health: Q1 Earnings Snapshot (Associated Press)
04:05PM	Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance (Business Wire)
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-04-26 08:05AM	Guardant Health Receives FDA Approval for Guardant360 CDx as a Companion Diagnostic for Arvinas and Pfizer's VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations (Business Wire)
Apr-30-26 08:05AM	Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity Platform (Business Wire)
04:05PM	Loading…
Apr-29-26 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Apr-16-26 04:05PM	Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026 (Business Wire) +5.44%
Apr-08-26 11:38AM	OS Therapies Appoints Craig Eagle, MD as Strategic Advisor (TMX Newsfile)
Mar-30-26 08:05AM	Guardant Health's InfinityAI Real-World Evidence Supports Approval of ENHERTU for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan (Business Wire)
08:00AM	Gamehost Enters into Definitive Agreement to Be Acquired by Pure Casino Entertainment for $13.65 per Share (TMX Newsfile)
Mar-24-26 09:15AM	Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data (PR Newswire)
Mar-18-26 08:53PM	Gamehost to Correct Administrative Expense Allocation in Financial Statements; No Impact on Operations or Cash Flow (TMX Newsfile)
08:05AM	Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 (Business Wire)
Mar-16-26 08:05AM	Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership (Business Wire)
Mar-13-26 08:05AM	New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare (Business Wire)
Mar-10-26 08:05AM	Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics (Business Wire)
Mar-05-26 11:51AM	BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? (Zacks)
08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 07:00AM	Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America (Business Wire)
Mar-03-26 07:00AM	Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened (Business Wire)
02:57AM	Loading…
Mar-02-26 02:57AM	Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition (Insider Monkey)
Feb-27-26 04:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-26 05:00PM	Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. (Barrons.com)
07:48AM	Guardant Health (GH) Gained from Better-Than-Expected Results (Insider Monkey)
Feb-23-26 06:50PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -8.42%
01:20PM	Guardant Health acquires MetaSight amid positive 2026 financial outlook (Medical Device Network)
12:00PM	Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know (StockStory)
12:52AM	Guardant buys MetaSight for $59M upfront to acquire blood test tech (MedTech Dive)
Feb-20-26 08:30AM	Guardant Health, Inc. Q4 2025 Earnings Call Summary (Moby)
12:02AM	Guardant Health Inc (GH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-26 09:10PM	Guardant Health Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Compared to Estimates, Guardant Health (GH) Q4 Earnings: A Look at Key Metrics (Zacks)
06:00PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:42PM	Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales (StockStory)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook (Business Wire)
Feb-18-26 05:04PM	Walmart To Report Results, Fresh Off New Highs, A New CEO And $1 Trillion Market Cap (Investor's Business Daily)
Feb-17-26 10:08PM	Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow (StockStory)
06:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
10:09AM	What Makes Guardant Health (GH) a Good Healthcare Holding (Insider Monkey)
08:04AM	Palo Alto Earnings Due. How Will Deal Blitz Impact Guidance? (Investor's Business Daily)
Feb-14-26 09:37AM	Boeing Holds In Buy Zone, Leads 5 Stocks To Watch In Short Trading Week (Investor's Business Daily)
Feb-13-26 08:22PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
03:38PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes New Buy Point (Investor's Business Daily)
10:20AM	Walmart Stock, Parade Of Gold Leaders Headline Another Busy Earnings Calendar (Investor's Business Daily)
Feb-12-26 02:35PM	Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open (PR Newswire)
10:00AM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know (Zacks)
09:10AM	Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates (Zacks)
Feb-11-26 07:28PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Feb-06-26 07:15AM	Long-Time Bear On Palantir Stock Says More Selling Still To Come (Investor's Business Daily)
Feb-05-26 07:32PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -7.34%
05:35PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-04-26 05:45PM	Palantir Retreats After Q4 Earnings Pop. Will 'N of 1' Story Work? (Investor's Business Daily) -6.10%
Feb-03-26 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
08:03AM	Stock Market Week: Dow Rally Aces Ninth Month (Investor's Business Daily)
Feb-02-26 04:27PM	Palantir Rebuts Bears With Earnings Beat, Guidance Above Views (Investor's Business Daily)
08:05AM	Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions (Business Wire)
Jan-30-26 05:04AM	Should You Buy Guardant Health Before Feb. 19? (Motley Fool)
Jan-29-26 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 (Business Wire)
Jan-23-26 07:40AM	Wall Street Has a Positive Opinion on Guardant Health (GH) (Insider Monkey)
Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
08:05AM	Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for BRAFTOVI (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
Jan-20-26 08:54AM	Strong Results and Improved Guidance Lifted Guardant Health (GH) in Q4 (Insider Monkey)
04:58AM	Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build (Insider Monkey)
Jan-19-26 08:05AM	Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform (Business Wire)
Jan-17-26 05:30AM	Supersize CEO Pay Packages Aren't Paying Off for Shareholders (The Wall Street Journal)
Jan-14-26 10:35PM	Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group (StockStory)
Jan-11-26 05:00PM	Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results (Business Wire)
01:10AM	Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) (Insider Monkey)
Jan-10-26 08:00AM	Google, Shopify Lead Big 2025 Winners Near New Buy Points (Investor's Business Daily)
Jan-09-26 02:24PM	Clinical Labs Hope to Head Off Looming Medicare Cuts (Barrons.com)
Jan-08-26 01:30PM	Guardant Health Catapults 234%; Sets Up With Strong Sales Outlook (Investor's Business Daily)
10:31AM	Cathie Wood Dumps $12.7 Million Worth of Meta Stock Amid Ray-Ban Smart Glasses Delay, Ark Loads Up On This Gaming Platform (Benzinga)
08:05AM	Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families (Business Wire)
Jan-06-26 06:54PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +10.27%
Dec-31-25 11:33AM	Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside (Insider Monkey)
Dec-29-25 04:05PM	Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
07:59AM	Stock Market Today: Dow Down From Record Highs; Nvidia, Tesla Slide (Live Coverage) (Investor's Business Daily)
Dec-27-25 08:05AM	Palantir, Nvidia Lead 5 Stocks Near Buy Points Heading Into Final Days Of 2025 (Investor's Business Daily)
Dec-26-25 05:23PM	Dow Jones Futures: Tesla, Nvidia Lead 5 Giants In Buy Areas; Market Strong As 2025 Nears End (Investor's Business Daily)
03:41PM	Medical Stocks On The Move In Top Growth List As Health Sector Performance Brightens (Investor's Business Daily)
Dec-22-25 10:19PM	Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth (Insider Monkey)
Dec-16-25 10:41AM	Guardant Health price target raised to $120 from $100 at BofA (TipRanks)
Dec-11-25 08:05AM	Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. (Business Wire)
Dec-09-25 10:19AM	Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run? (Zacks)
08:05AM	Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy (Business Wire)
Dec-08-25 10:15AM	Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook (Zacks)
Dec-05-25 06:42PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -5.99%
09:41AM	Tempus AI: Revenue Mix and 2026 Growth Outlook Explained (Zacks)
08:05AM	Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium (Business Wire)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Co-FounderDr. Helmy Eltoukhy Ph.D.

Co-CEO & DirectorDr. AmirAli Talasaz Ph.D.

Chief Financial OfficerMr. Michael Bell

Chief Technology OfficerDr. Darya Chudova

Chief Legal Officer & Corporate SecretaryMr. John G. Saia J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Krognes Steve E.	Director	Jun 04 '26	Sale	132.51	9,294	1,231,522	10,222	Jun 05 07:50 PM
Eltoukhy Helmy	Officer	Jun 05 '26	Proposed Sale	126.30	100,000	12,629,970		Jun 05 04:38 PM
Bell Michael Brian	Officer	Jun 05 '26	Proposed Sale	128.62	2,000	257,241		Jun 05 04:02 PM
Joyce Meghan V.	Director	Jun 03 '26	Option Exercise	38.05	10,000	380,547	21,183	Jun 04 06:07 PM
Joyce Meghan V.	Director	Jun 03 '26	Sale	126.98	10,000	1,269,809	11,183	Jun 04 06:07 PM
Krognes Steve E.	Director	Jun 04 '26	Proposed Sale	132.51	9,294	1,231,522		Jun 04 04:10 PM
Joyce Meghan V.	Director	Jun 03 '26	Proposed Sale	126.98	10,000	1,269,809		Jun 03 04:06 PM
Krognes Steve E.	Director	May 31 '26	Option Exercise	0.00	154	0	19,516	Jun 01 05:30 PM
Hidalgo Medina Manuel	Director	May 28 '26	Sale	130.06	1,000	130,060	639	May 29 05:30 PM
Saia John G.	Chief Legal Officer	May 27 '26	Sale	125.08	10,000	1,250,836	35,950	May 28 06:32 PM
Hidalgo Medina Manuel	Director	May 28 '26	Proposed Sale	130.06	1,000	130,060		May 28 04:01 PM
Freeman Chris	Chief Commercial Officer	May 22 '26	Option Exercise	32.86	24,406	801,981	84,440	May 26 05:38 PM
Freeman Chris	Chief Commercial Officer	May 22 '26	Sale	118.67	24,406	2,896,360	60,034	May 26 05:38 PM
EAGLE CRAIG	Former Affiliate	May 22 '26	Proposed Sale	118.72	160,817	19,091,422		May 22 05:44 PM
Freeman Chris	Officer	May 22 '26	Proposed Sale	118.67	24,406	2,896,361		May 22 05:43 PM
Saia John G.	Chief Legal Officer	May 20 '26	Sale	106.51	20,000	2,130,229	45,950	May 22 04:58 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 20 '26	Sale	109.89	210,000	23,076,690	1,886,504	May 22 04:57 PM
CLARK IAN T	Director	May 20 '26	Sale	106.90	6,876	735,049	2,975	May 22 04:57 PM
Hidalgo Medina Manuel	Director	May 20 '26	Option Exercise	32.55	1,000	32,550	2,889	May 22 04:56 PM
Hidalgo Medina Manuel	Director	May 20 '26	Sale	107.09	1,250	133,864	1,639	May 22 04:56 PM
Saia John G.	Officer	May 20 '26	Proposed Sale	106.51	30,000	3,195,345		May 20 04:31 PM
CLARK IAN T	Director	May 20 '26	Proposed Sale	106.90	6,876	735,049		May 20 04:04 PM
Hidalgo Medina Manuel	Director	May 20 '26	Proposed Sale	107.09	1,250	133,864		May 20 04:03 PM
Tariq Musa	Director	May 15 '26	Option Exercise	0.00	250	0	8,778	May 19 06:02 PM
Tariq Musa	Director	May 18 '26	Sale	95.96	116	11,131	8,662	May 19 06:02 PM
Hidalgo Medina Manuel	Director	May 17 '26	Option Exercise	0.00	232	0	1,889	May 19 06:01 PM
Chudova Darya	Chief Technology Officer	May 15 '26	Option Exercise	0.00	8,705	0	79,081	May 19 06:01 PM
Tariq Musa	Director	May 18 '26	Proposed Sale	95.96	116	11,131		May 18 04:12 PM
Talasaz AmirAli	Co-Chief Executive Officer	May 12 '26	Sale	100.32	50,000	5,016,000	2,096,504	May 13 05:32 PM
Talasaz AmirAli	Officer	May 12 '26	Proposed Sale	100.32	260,000	26,083,200		May 12 06:13 PM
Krognes Steve E.	Director	Apr 30 '26	Option Exercise	0.00	154	0	19,362	May 01 05:45 PM
MIGNONE ROBERTO	Director	Apr 21 '26	Option Exercise	0.00	264	0	4,751	Apr 22 06:17 PM
Hidalgo Medina Manuel	Director	Apr 17 '26	Option Exercise	0.00	232	0	1,657	Apr 20 06:20 PM
Tariq Musa	Director	Apr 15 '26	Option Exercise	0.00	250	0	8,644	Apr 16 07:58 PM
Tariq Musa	Director	Apr 16 '26	Sale	84.83	116	9,840	8,528	Apr 16 07:58 PM
Saia John G.	Chief Legal Officer	Apr 15 '26	Option Exercise	0.00	7,569	0	69,920	Apr 16 07:58 PM
Tariq Musa	Director	Apr 16 '26	Proposed Sale	84.83	116	9,840		Apr 16 04:01 PM
Monroe Terilyn J.	Chief People Officer	Apr 06 '26	Sale	92.68	3,832	355,150	20,990	Apr 07 05:40 PM
Monroe Terilyn J.	Officer	Apr 06 '26	Proposed Sale	92.68	3,832	355,150		Apr 06 04:03 PM
Saia John G.	Chief Legal Officer	Apr 01 '26	Option Exercise	0.00	11,461	0	68,364	Apr 02 05:24 PM
Monroe Terilyn J.	Chief People Officer	Apr 01 '26	Option Exercise	0.00	8,019	0	29,009	Apr 02 05:23 PM
Kalia Kumud	Chief Information Officer	Apr 01 '26	Option Exercise	0.00	10,044	0	54,341	Apr 02 05:22 PM
Freeman Chris	Chief Commercial Officer	Apr 01 '26	Option Exercise	0.00	11,213	0	64,784	Apr 02 05:22 PM
EAGLE CRAIG	Chief Medical Officer	Apr 01 '26	Option Exercise	0.00	11,400	0	77,780	Apr 02 05:21 PM
Chudova Darya	Chief Technology Officer	Apr 01 '26	Option Exercise	0.00	13,029	0	77,381	Apr 02 05:21 PM
Bell Michael Brian	Chief Financial Officer	Apr 01 '26	Option Exercise	0.00	12,777	0	56,378	Apr 02 05:20 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 31 '26	Option Exercise	0.00	2,817	0	2,131,306	Apr 02 05:19 PM
Talasaz AmirAli	Co-Chief Executive Officer	Apr 01 '26	Option Exercise	0.00	33,713	0	2,163,591	Apr 02 05:19 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 31 '26	Option Exercise	0.00	2,817	0	2,097,721	Apr 02 05:19 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Apr 01 '26	Option Exercise	0.00	33,713	0	2,130,006	Apr 02 05:19 PM
Krognes Steve E.	Director	Mar 31 '26	Option Exercise	0.00	155	0	19,208	Apr 01 05:31 PM
MIGNONE ROBERTO	Director	Mar 21 '26	Option Exercise	0.00	264	0	4,487	Mar 23 04:19 PM
Tariq Musa	Director	Mar 18 '26	Sale	88.09	348	30,655	8,394	Mar 19 05:16 PM
Hidalgo Medina Manuel	Director	Mar 17 '26	Option Exercise	0.00	232	0	1,425	Mar 18 05:40 PM
Tariq Musa	Director	Mar 18 '26	Proposed Sale	88.09	348	30,655		Mar 18 04:05 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	38,283	0	2,134,594	Mar 17 09:57 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 13 '26	Option Exercise	0.00	26,961	0	2,142,153	Mar 17 09:57 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	38,283	0	2,101,009	Mar 17 09:57 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 13 '26	Option Exercise	0.00	26,961	0	2,108,568	Mar 17 09:57 PM
Tariq Musa	Director	Mar 15 '26	Option Exercise	0.00	249	0	8,742	Mar 17 06:49 PM
Saia John G.	Chief Legal Officer	Mar 15 '26	Option Exercise	0.00	8,811	0	61,525	Mar 17 06:49 PM
Kalia Kumud	Chief Information Officer	Mar 15 '26	Option Exercise	0.00	13,493	0	51,136	Mar 17 06:48 PM
Freeman Chris	Chief Commercial Officer	Mar 15 '26	Option Exercise	0.00	16,828	0	60,698	Mar 17 06:48 PM
EAGLE CRAIG	Chief Medical Officer	Mar 15 '26	Option Exercise	0.00	15,114	0	74,041	Mar 17 06:46 PM
Chudova Darya	Chief Technology Officer	Mar 15 '26	Option Exercise	0.00	10,714	0	70,111	Mar 17 06:46 PM
Bell Michael Brian	Chief Financial Officer	Mar 15 '26	Option Exercise	0.00	13,790	0	54,014	Mar 17 06:46 PM
Bell Michael Brian	Chief Financial Officer	Mar 16 '26	Sale	87.04	3,000	261,111	43,601	Mar 17 06:46 PM
Bell Michael Brian	Officer	Mar 16 '26	Proposed Sale	87.04	3,000	261,111		Mar 16 04:07 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Option Exercise	32.55	1,000	32,550	2,493	Mar 09 06:38 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Sale	91.54	1,300	118,997	1,193	Mar 09 06:38 PM
Hidalgo Medina Manuel	Director	Mar 06 '26	Proposed Sale	91.54	1,300	118,997		Mar 06 04:19 PM
Kalia Kumud	Chief Information Officer	Mar 04 '26	Option Exercise	37.48	43,119	1,616,117	77,643	Mar 05 05:44 PM
Kalia Kumud	Chief Information Officer	Mar 04 '26	Sale	95.32	40,000	3,812,661	37,643	Mar 05 05:44 PM
Kalia Kumud	Officer	Mar 04 '26	Proposed Sale	95.32	40,000	3,812,660		Mar 04 04:06 PM
Krognes Steve E.	Director	Feb 28 '26	Option Exercise	0.00	154	0	19,053	Mar 02 04:24 PM
MIGNONE ROBERTO	Director	Feb 21 '26	Option Exercise	0.00	264	0	4,223	Feb 23 05:47 PM
Hidalgo Medina Manuel	Director	Feb 17 '26	Option Exercise	0.00	232	0	1,493	Feb 18 04:27 PM
Tariq Musa	Director	Feb 15 '26	Option Exercise	0.00	250	0	8,493	Feb 17 06:31 PM
Krognes Steve E.	Director	Jan 31 '26	Option Exercise	0.00	154	0	18,899	Feb 02 04:30 PM
Monroe Terilyn J.	Chief People Officer	Jan 21 '26	Sale	114.09	8,571	977,902	20,990	Jan 22 05:45 PM
MIGNONE ROBERTO	Director	Jan 21 '26	Option Exercise	0.00	264	0	3,959	Jan 22 05:44 PM
Monroe Terilyn J.	Officer	Jan 21 '26	Proposed Sale	114.09	8,571	977,902		Jan 21 04:10 PM
Hidalgo Medina Manuel	Director	Jan 17 '26	Option Exercise	0.00	232	0	1,261	Jan 20 04:47 PM
Tariq Musa	Director	Jan 15 '26	Option Exercise	0.00	250	0	8,243	Jan 16 04:39 PM
Monroe Terilyn J.	Chief People Officer	Jan 15 '26	Option Exercise	0.00	17,379	0	38,369	Jan 16 04:39 PM
Monroe Terilyn J.	Chief People Officer	Jan 07 '26	Sale	112.08	10,031	1,124,279	20,990	Jan 09 04:09 PM
Monroe Terilyn J.	Officer	Jan 07 '26	Proposed Sale	112.07	10,031	1,124,200		Jan 07 04:03 PM
Saia John G.	Chief Legal Officer	Jan 01 '26	Option Exercise	0.00	19,046	0	62,703	Jan 05 06:01 PM
Monroe Terilyn J.	Chief People Officer	Jan 01 '26	Option Exercise	0.00	17,555	0	38,545	Jan 05 06:01 PM
Kalia Kumud	Chief Information Officer	Jan 01 '26	Option Exercise	0.00	21,237	0	43,916	Jan 05 06:00 PM
Freeman Chris	Chief Commercial Officer	Jan 01 '26	Option Exercise	0.00	27,237	0	54,032	Jan 05 05:59 PM
EAGLE CRAIG	Chief Medical Officer	Jan 01 '26	Option Exercise	0.00	25,442	0	70,449	Jan 05 05:58 PM
Chudova Darya	Chief Technology Officer	Jan 01 '26	Option Exercise	0.00	22,732	0	29,744	Jan 05 05:57 PM
Bell Michael Brian	Chief Financial Officer	Jan 01 '26	Option Exercise	0.00	23,038	0	52,703	Jan 05 05:57 PM
Talasaz AmirAli	Co-Chief Executive Officer	Dec 31 '25	Option Exercise	0.00	4,815	0	2,002,689	Jan 05 05:56 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	23,997	0	2,024,245	Jan 05 05:56 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Dec 31 '25	Option Exercise	0.00	4,815	0	2,051,958	Jan 05 05:55 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jan 01 '26	Option Exercise	0.00	23,997	0	2,073,514	Jan 05 05:55 PM
Krognes Steve E.	Director	Dec 31 '25	Option Exercise	0.00	154	0	18,745	Jan 05 05:54 PM
MIGNONE ROBERTO	Director	Dec 21 '25	Option Exercise	0.00	264	0	3,695	Dec 23 07:25 PM

GH

Guardant Health Inc

DNLI

Denali Therapeutics Inc

Upgrade your Finviz experience